Organon OGN Nexplanon/Implanon NXT — Number of pending claims

Other product segments

Similar metrics at other companies

CLOVInsurance Operations — Unpaid claims

$260.4M+72.5%

ACTDomestic mortgage insurance — Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year, Net

$105K+6.1%

CIOther — Unpaid claims and claim expenses, current

$152M-11.6%

CICigna Healthcare — Liability for Unpaid Claims and Claims Adjustment Expense, Net

$4.78B+9.4%

PRVALiability for Unpaid Claims and Claims Adjustment Expense, Net

$518.63M+29.6%

SKWDExited Lines — Short-Duration Insurance Contract, Cumulative Number of Reported Claims

566,000%+2,800pp

Questions, answered.

What is Organon's nexplanon/implanon NXT — number of pending claims?

Organon (OGN) reported nexplanon/implanon NXT — number of pending claims of $19 in Q1 2026.

How has Organon's nexplanon/implanon NXT — number of pending claims changed year-over-year?

Organon's nexplanon/implanon NXT — number of pending claims decreased by 0.0% year-over-year, from $19 to $19.

What is the long-term trend for Organon's nexplanon/implanon NXT — number of pending claims?

Over 4 years (2021 to 2025), Organon's nexplanon/implanon NXT — number of pending claims has grown at a -6.0% compound annual growth rate (CAGR), from $91 to $71.

What does nexplanon/implanon NXT — number of pending claims mean?

This metric quantifies the volume of outstanding insurance or reimbursement claims associated with the specific product line that have been submitted but not yet finalized or paid. It provides insight into the efficiency of the revenue cycle management process and potential liquidity constraints related to accounts receivable. High levels of pending claims may indicate administrative bottlenecks or challenges in payer coverage and reimbursement policies.